Biotalys NV
3,3000
24-января-25 03:54:39
15 мин. задержка
Акции
0,0000
0,00%
Сегодняшний диапазон
3,3000 - 3,3000
ISIN
BE0974386188
Источник
Cboe
- Котировки
- Графики
Новости
- Статистика
-
Biotalys Creates Scientific Advisory Committee with Leading Experts
01 дек 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Invitation to an Extraordinary Shareholders’ Meeting
25 ноя 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys announces participation at investor and industry events for the remainder of 2022
07 ноя 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
31 окт 2022 12:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys and Novozymes announce successful Evoca™ feasibility study
24 окт 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys announces participation at investor and industry events for the upcoming months
13 сен 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys Reports Half-Year 2022 Financial Results and Business Highlights
19 авг 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
29 июл 2022 11:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys and Novozymes Enter into Partnership to Expand Opportunities for Evoca™
21 июн 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys’ First Biocontrol Evoca Wins World BioProtection Award 2022 for Best Biofungicide Product
25 май 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Latest Field Trials Validate Strength of Biotalys’ First Biocontrol Evoca
19 май 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys Obtains New Fungicide Resistance Class for its First Biofungicide
03 май 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
29 апр 2022 11:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys Appoints Michiel van Lookeren Campagne to Board of Directors
19 апр 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Results of the Annual and Extraordinary Shareholders’ Meetings
15 апр 2022 11:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys Appoints Carlo Boutton as Chief Scientific Officer
31 мар 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Invitation to the Annual and Extraordinary Shareholders’ Meetings
15 мар 2022 01:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys Reports Full Year 2021 Financial Results and Business Highlights
11 мар 2022 00:00:00 Источник Nasdaq GlobeNewswire
-
Biotalys Notice of Full Year 2021 Results and Business Highlights
15 фев 2022 11:00:00 Источник Nasdaq GlobeNewswire
-
Information on the total number of voting rights and shares
31 янв 2022 00:00:00 Источник Nasdaq GlobeNewswire